Wednesday, 25. August 2021

Presenting the Straumann portfolio

Presenting the Straumann portfolio

A globally renowned brand, Straumann will present an array of its industry-leading solutions at the ITI Congress. Among these you can expect to discover the latest generation implants and biomaterials to support exceptional treatment outcomes.

Introducing the Straumann TLX

The TLX offers the best of both worlds – the aesthetics of a tissue level implant with the stability of a bone level implant needed for confidence in immediacy. It has been designed to mimic the natural anatomy and respect the biological distance in all dimensions for ideal soft tissue conditioning.

While optimised for immediate protocols, it supports conventional placement and loading procedures for flexibility and uses the same drill set / TorcFit connection as the Straumann BLX bone level implant for convenience.  

Ross Cutts, Principal of Cirencester Dental Practice, shares his first impressions of the implant:

“The new TLX provides the same level of primary stability that the BLX affords, but with a tissue level connection and restorative interface. I like that the TLX is very similar in all other aspects. It features the same thread pitch design, which optimises the primary stability achieved, especially in posterior maxilla sites. Based on my first experience with the new implant, I really like the concept – it just makes sense to me.”

A trusted favourite

Of course, the Straumann BLX is going nowhere, remaining a favourite among clinicians in the UK and around the globe. It has been refined to maximise outcomes in a range of clinical indications, delivering total peace of mind for next level immediacy.

Its innovative SLActive surface promotes effective bone regeneration, even in compromised sites,[i][ii][iii][iv] enhancing predictability for highly successful immediate loading protocols[v] and reducing healing time to 3-4 weeks in some cases.[vi][vii]

This is all supported by the innovative Roxolid material, which preserves the natural structures and boosts vascularisation.[viii][ix]

Dr Abid Faqir, is a Past President of the ADI and clinician at Scottish Centre for Excellence in Dentistry, comments:

“I use the Straumann BLX implant for immediacy, because it was designed with immediacy in mind and everything about it and its characteristics are exactly what an immediate implant needs to be. For example, it enables very high primary stability and the SLActive implant surface is perfectly suited for faster healing. Restoratively, it has the perfect connection and all the various components are available to allow immediate restoration.”

The complete picture

Catering for every step in the implant workflow, Straumann offers a comprehensive portfolio of biomaterials to support exceptional bone and soft tissue management. This includes xenograft, allograft and synthetic graft materials, as well as resorbable and non-resorbable barrier membranes. Together, they make clinicians the master of any challenge – no matter how complex.

Dr Andoni Jones, clinician at 3Dental in Dublin, comments:

“I have been using Straumann Group biomaterials for 10 years now. A wide range of clinically proven materials are available, so the Straumann portfolio offers me solutions for most of my day-to-day clinical cases. 

“In particular, I use MaxGraft for most of my infrabony defects, which include extraction sockets. I like its fast and reliable turnover into natural bone, whilst maintaining volume stability. Whenever I want to gain volume outside of the bone contours, my biomaterial of choice is cerabone. This provides space maintenance and a long-term scaffold for tissue growth, plus it's very hydrophilic.” 

For all this and more, drop by the Straumann stand!

 

 

For more details, please visit www.straumann.com



[i] Kuchler U, Chappuis V, Bornstein mm, Siewczyk M, Gruber R, Maestre L, Buser D. Development of Implant Stability Quotient values of implants placed with simultaneous sinus floor elevation – results of a prospective study with 109 implants. Clin. Oral Impl. Res. 28, 2017, 109– 115.

[ii] Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA® titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (2007): 78–86.

[iii] Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (2008): 64–75.

[iv] El Chaar E, Zhang L, Zhou Y, et al. (Superior) osseointegration of super hydrophilic implants placed in defect grafted bones. Int J Oral Maxillofac Implants 2018. (article in press).

[v] Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J. 10-year outcomes with immediate and early-loaded implants with a chemically modified SLA surface, Quintessence Int. (article in press).

[vi] ­­ Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD. Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants Res. 2011 Apr;22(4):349-56. doi:10.1111/j.1600-0501.2011.02172.x

[vii] Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL. Enhanced implant stability with a chemically modified SLA surface: a randomized pilot study. Int J Oral Maxillofac Implants. 2007 Sep-Oct;22(5):755-60

[viii] Ioannidis A, Gallucci GO, Jung RE, Borzangy S, Hämmerle CH, Benic GI. Titanium-zirconium narrow-diameter versus titanium regular diameter implants for anterior and premolar single crowns: 3-year results of a randomized controlled clinical study. J Clin Periodontol. 2015 Nov;42(11):1060-70. doi: 10.1111/jcpe.12468. Epub 2015 Nov 14.

[ix] Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz- Vigón A, Rousseau P, Tondela J. A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium Alloy. J Oral Implantol. 2015 Aug;41(4):e118-25. doi: 10.1563/AAID-JOI-D-13-00149. Epub 2014 Mar 25.

SCIENTIFIC HOST ORGANIZATION
ITI International Team for Implantology
ITI Headquarters

Peter Merian-Weg 10
4052 Basel, Switzerland

ITI Congress UK & Ireland | EdinburghOctober 1-2 2021 | www.events.iti.org/congressuk-ireland




By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.
More information about cookies

I agree